Case Studies

Multi-Year Global Vaccine Monitoring Project​

Posted by | Fuld & Company

Background and Challenge

A leading manufacturer of multiple infectious disease vaccines used Fuld & Company’s competitive monitoring services to gain a clear view of the evolving competitive landscape. The client needed to assess its competitors’ near and long-term pipeline programs from Phase I through Phase III in several global infectious disease areas. 

Our Solution

Our competitive monitoring solution included:

  • Conducting monthly monitoring and intelligence gathering in a variety of infectious disease areas each year.
  • Using a customized schedule of monthly topics to report on a quarterly basis to give the client flexibility based on the dynamics of the market.​
  • Attending multiple international conferences across the globe to gain further insights. ​
  • Investigating clinical trials, scientific material, analyst sources, and corporate material to assess the competitors’ pipelines. ​
  • Leveraging the knowledge of the client’s employees to maximize novel findings.

Results

The monitoring program provided the client with a wide variety of details about its global competitors’ current and future product development activities. The findings included information about product prioritization, clinical trials, regulatory submissions, and commercial development strategies in several areas including licensing/partnering, marketing, and promotion. ​

With this information, the client could make better decisions about its own clinical trial design, development timelines, and commercial planning. As the competitors’ programs progressed from Phase I to registration trials, the flexibility of the Fuld program allowed the client to increase coverage of different key topics as needed.

Tags: , ,

Related Resources

Read More

Global medical equipment company discovers a new competitor…and a new market

A leading medical equipment manufacturer was concerned about a new entrant that had moved into one of its high-value, diagnostic […]

Read More

Identifying Drug Repurposing Collaboration Partners

A top pharma company actively working in the drug repurposing sector wanted to expand its portfolio by adding new indications […]

Read More

Identifying the most effective prophylactic/therapeutic oral anti-inflammatory agents

A global FMCG leader sought to expand their current oral care product range with a line of products that had […]

Subscribe to our mailing list for our latest updates:

Wednesday, February 15

10:30 ET | 15:30 GMT

Join us to learn about:

  • Cultural nuance issues
  • Methods to mitigate bias
  • Optimizing survey design
  • Interpreting global results